# Infantile Cataracts Associated with a Homozygous Missense MSMO1 Variant—Case Report and Literature Review

**Authors:** Nick Hassas, Andy Drackley, Jelena Ivanisevic, Hantamalala Ralay Ranaivo, Sudhi P. Kurup

PMC · DOI: 10.3390/reports9010045 · Reports - Clinical Practice and Surgical Cases · 2026-01-30

## TL;DR

A patient with infantile cataracts and developmental delays was found to have a rare genetic variant in the MSMO1 gene, which is linked to cholesterol synthesis and eye development.

## Contribution

This case expands the known clinical features of MSMO1 deficiency and its connection to infantile cataracts.

## Key findings

- A homozygous likely pathogenic variant in MSMO1 was identified in a patient with infantile cataracts and developmental delay.
- Impaired cholesterol synthesis due to MSMO1 deficiency is linked to early lens opacification and cataract formation.
- The case highlights the importance of cholesterol biosynthesis in early lens development.

## Abstract

Background and Clinical Significance: MSMO1, encoding a key enzyme in the cholesterol synthesis pathway, is associated with an autosomal recessive condition characterized by microcephaly, ocular abnormalities, growth delay, psoriasiform dermatitis, immune dysfunction, and intellectual disability. Case Presentation: This report describes a patient presenting with global developmental delay and bilateral infantile cataracts found to harbor a homozygous likely pathogenic MSMO1 variant and reviews the literature on MSMO1 deficiency and its association with infantile cataracts. Conclusions: The mechanism of early lens opacification is thought to result from impaired cholesterol synthesis, altering the lipid composition of the lens membrane and leading to early cataract formation. This case expands our understanding of MSMO1 deficiency and highlights the critical role of cholesterol biosynthesis in early lens development.

## Linked entities

- **Genes:** MSMO1 (methylsterol monooxygenase 1) [NCBI Gene 6307]
- **Diseases:** microcephaly (MONDO:0001149), intellectual disability (MONDO:0001071)

## Full-text entities

- **Genes:** PLEKHG2 (pleckstrin homology and RhoGEF domain containing G2) [NCBI Gene 64857] {aka ARHGEF42, CLG, CTB-60E11.4, LDAMD}, MSMO1 (methylsterol monooxygenase 1) [NCBI Gene 6307] {aka DESP4, ERG25, MCCPD, SC4MOL}
- **Diseases:** ocular abnormalities (MESH:D005124), developmental and growth delay (MESH:D006130), hyperpigmentation (MESH:D017495), poor vision (MESH:D014786), injury to (MESH:D014947), disease (MESH:D004194), autosomal recessive condition (MESH:D020763), joint contractures (MESH:D003286), spastic quadriplegia (MESH:D011782), psoriasis (MESH:D011565), psoriasiform dermatitis (OMIM:616834), genetic abnormalities (MESH:D030342), microcephaly (MESH:D008831), lens opacification (MESH:D007905), opacities (MESH:D003318), psoriasiform rash (MESH:D005076), cutaneous abnormalities (MESH:D018366), leukodystrophy (MESH:D007966), white matter injury (MESH:D056784), dry skin (MESH:D015352), immune dysfunction (MESH:D007154), intellectual disability (MESH:D008607), MSMO1 deficiency (MESH:D007153), developmental delay (MESH:D002658), esotropia (MESH:D004948), Cataracts (MESH:D002386)
- **Chemicals:** triglycerides (MESH:D014280), cholesterol (MESH:D002784), 4, 4'-dimethyl sterols (-), Sterol (MESH:D013261), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.343G>A, p.Gln1322Profs*19, p.Gly202Glu, p.Tyr244Cys, c.3964dup
- **Cell lines:** NM_ — Bos taurus (Bovine), Finite cell line (CVCL_3074), NM_006745.5 — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_B064)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922104/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12922104/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922104/full.md

---
Source: https://tomesphere.com/paper/PMC12922104